Pharmacology of Harmalan (1-methyl-3,4-dihydro-β-carboline)
- 1 March 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 109 (3) , 363-371
- https://doi.org/10.1016/0014-2999(85)90397-8
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- High affinity (3H)tryptamine binding sites in various organs of the ratLife Sciences, 1984
- Two metabolic pathways of tetrahydronorharmane (Tetrahydro-?-carboline) in ratsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- The anxiogenic action of benzodiazepine antagonistsNeuropharmacology, 1982
- .beta.-Carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptorsJournal of Medicinal Chemistry, 1982
- Interaction of Convulsive Ligands with Benzodiazepine ReceptorsScience, 1982
- Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepinesPharmacology Biochemistry and Behavior, 1980
- I. Liquid chromatography with pre-column sample enrichment and electrochemical detection. Regional determination of serotonin and 5-hydroxyindoleacetic acid in brain tissueLife Sciences, 1980
- Harman in human plateletsLife Sciences, 1979
- Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mousePsychopharmacology, 1968